OFFICIAL PUBLICATION OF

by its subsidiary APPco

New hepatitis C treatment approved

Megan Haggan 12/05/2015

liver cancer: "liver" spelled out on post-its hanging from line

The TGA has approved a new hepatitis C treatment, Gilead Sciences, Australia New Zealand, today announced. Harvoni (ledipasvir/ sofosbuvir) is the first daily single tablet regimen for the treatment of genotype one chronic hepatitis C (HCV) in adults. In clinical trials, it was shown that up to 99% of patients with HCV genotype one taking

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

‘I can feel the walls closing in on me as this snowballs’

I agree Christine. HMRs and RMMRs are really the success story of advanced practice in Australia. They are supported by…

Debbie Rigby

New hepatitis C treatment approved

Previous Pharmacists' Support Service thanks volunteers

Next Pymble Public School in hearty stunt

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Pharmacists' Support Service thanks volunteers

Next Pymble Public School in hearty stunt

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.